 SPARTA, N.J., Nov. 01, 2021 GLOBE NEWSWIRE -- PLx Pharma Inc. NASDAQ: PLXP PLx or the Company, is a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuardTM drug delivery platform that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs. The Company, with its lead products VAZALORETM 325 mg and VAZALORETM 81 mg liquid-filled aspirin capsules referred to together as VAZALORE, announced today that it will release 2021 third quarter financial results on Friday, November 12, 2021, before the U.S. financial markets open. 